Merck (MRK) Profit After Tax (2009 - 2026)

Merck (MRK) posted quarterly Profit After Tax of -$4.2 billion for Q1 2026, down 183.48% YoY from $5.1 billion in Q1 2025, and down 243.15% sequentially from $3.0 billion in Q4 2025.

Merck (MRK) Profit After Tax (2009 - 2026) Analysis & Trends

Merck has disclosed Profit After Tax across 18 years of filings, most recently posting -$4.2 billion for Q1 2026.

  • In Q1 2026, Profit After Tax fell 183.48% year-over-year to -$4.2 billion; the TTM figure through Mar 2026 stood at $8.9 billion (down 48.74% YoY), while the FY2025 annual figure was $18.3 billion, up 6.7% from the prior year.
  • Profit After Tax retreated to -$4.2 billion in Q1 2026, from $3.0 billion in the prior quarter.
  • Over the last five years, Profit After Tax for MRK reached as high as $5.8 billion in Q3 2025 and fell as low as -$6.0 billion in Q2 2023.
  • The 5-year median for Profit After Tax is $3.7 billion (2024), against an average of $2.7 billion.
  • Annual changes were most pronounced in 2023 — Profit After Tax sank 251.5% — and 2024, when it surged 407.08%.
  • A 5-year view of Profit After Tax shows it stood at $3.0 billion in 2022, then slumped by 140.24% to -$1.2 billion in 2023, then surged by 407.08% to $3.7 billion in 2024, then decreased by 20.55% to $3.0 billion in 2025, then slumped by 243.15% to -$4.2 billion in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$4.2 billion, $3.0 billion, and $5.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.40 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 5.24 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 697.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 3.08 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -4.24 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.02 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.71 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 319.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.24 Bn
Dec 31, 2025 2.96 Bn
Sep 30, 2025 5.79 Bn
Jun 30, 2025 4.43 Bn
Mar 31, 2025 5.08 Bn
Dec 31, 2024 3.73 Bn
Sep 30, 2024 3.16 Bn
Jun 30, 2024 5.46 Bn
Mar 31, 2024 4.76 Bn
Dec 31, 2023 -1.21 Bn
Sep 30, 2023 4.75 Bn
Jun 30, 2023 -5.98 Bn
Mar 31, 2023 2.82 Bn
Dec 31, 2022 3.02 Bn
Sep 30, 2022 3.25 Bn
Jun 30, 2022 3.94 Bn
Mar 31, 2022 4.31 Bn
Dec 31, 2021 3.05 Bn
Sep 30, 2021 4.57 Bn
Jun 30, 2021 1.55 Bn